Is “people not working because they’re too fat” really a thing in the UK? It sounds like a fever dream brought on by reading too many Daily Mail editorials.
I am actually all for this being offered on the NHS as a voluntary option. Obviously making it a condition of benefits is just batshit crazy. It is sadly what we expect from the Tories these days. However for those with real issues and a desire to solve them then maybe this can help. There are side effects to using the drugs. People should always understand the risks. You never something for nothing in this life.
https://www.independent.co.uk/news/health/ozempic-wegovy-side-effects-safe-b2424617.html
They found those using weight loss jabs were 9.09 times more likely to suffer inflammation of the pancreas, which can, in some cases require surgery
They were also 4.22 times more likely to develop a bowel obstruction and were at a 3.67 higher risk of gastroparesis, or “stomach paralysis”, which limits the passage of food from the stomach to the small intestine.
First author Mohit Sodhi, a graduate of UBC’s experimental medicine programme and fourth year UBC medical student, said: “Given the wide use of these drugs, these adverse events, although rare, must be considered by patients thinking about using them for weight loss.
“People who are otherwise healthy may be less willing to accept these potentially serious adverse events.”
This is the best summary I could come up with:
Internal documents obtained by the Observer reveal that Pinder Sahota, corporate vice-president of Novo Nordisk UK, told the then health secretary Steve Barclay, England’s chief medical officer and Treasury officials that “data from the Department for Work and Pensions [DWP] could help profile those who are most likely to return to the labour market”.
During the meeting, attendees discussed the potential socioeconomic benefits of making weight-loss injections available in a community-based pilot scheme alongside “wraparound support”, such as back-to-work counselling.
In March, the Times reported that “millions of people could be offered a new generation of weight-loss drugs under plans to turn the tide on obesity and get benefit claimants back to work”, after an apparent briefing by officials.
A joint announcement from the prime minister and the Department of Health in June 2023 said that potential effects of the pilot included cutting NHS waiting lists and “wider economic benefits”.
Prof Simon Capewell, a public health policy expert and emeritus professor at Liverpool University, said the comments by Novo Nordisk executives were “shocking and “absolutely unethical”.
Labour MP Debbie Abrahams, co-chair of the all-party parliamentary group on universal credit and a member of the Work and Pensions Committee, said the suggestion from Novo Nordisk to target benefit claimants was “very worrying on several levels”.
The original article contains 1,287 words, the summary contains 214 words. Saved 83%. I’m a bot and I’m open source!
